arrow
S

Shogo Kobayashi

University of Osaka
H指数:54
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Zolbetuximab-based chemotherapy in CLDN18.2-positive gastric cancer: real-world tumor response and early albumin kinetics

Zolbetuximab联合化疗在CLDN18.2阳性胃癌中的应用:真实世界肿瘤反应及早期白蛋白动力学

2026-02-010
PRE
A single-center retrospective study of conversion surgery in stage IV gastric cancer: association with immune checkpoint inhibitor-based chemotherapy

单中心回顾性研究:IV期胃癌转化手术与基于免疫检查点抑制剂化疗的相关性

2026-01-011
PRE
Can preoperative spirometry be omitted for HBP surgery?

术前肺量测定能否在HBP手术中省略?

2026-01-010
PRE
Assessment of Surgical Invasiveness in Hepatobiliary and Pancreatic Surgeries by Quantifying Intraoperative Energy Expenditure: A Comparison Between Laparoscopic and Open Surgery

通过量化术中能量消耗评估肝胆胰手术的手术侵袭性:腹腔镜手术与开腹手术的比较

2025-12-040
PRE
LSECs promote MASH progression via IL-1R1-mediated chemokine production induced by macrophage-derived IL-1β

肝窦内皮细胞(LSECs)通过巨噬细胞来源的IL-1β诱导的IL-1R1介导的趋化因子产生促进MASH进展。

2025-12-020
OAAI
IL-33 released during liver resection facilitates intrahepatic cholangiocarcinoma growth via cytokine secretion in cancer-associated fibroblasts

肝切除术期间释放的IL-33通过癌症相关成纤维细胞中的细胞因子分泌促进肝内胆管癌生长。

2025-11-230
PRE
Clinical outcomes of 23-mm circular stapled cervical anastomosis after esophagectomy
2025-11-010
PRE
Robotic esophageal reconstruction with a diagonal stapling technique: technical description and early outcomes from a single-center series

机器人食管重建术采用对角线吻合技术:技术描述和单中心系列研究的早期结果

2025-11-010
PRE
Neoadjuvant Chemotherapy With Gemcitabine/Cisplatin/S-1 for Resectable Biliary Tract Cancer With FDG-PET-Positive Lymph Node Metastasis (KHBO1201): A Multicenter Phase II Trial

新辅助化疗联合吉西他滨/顺铂/S-1治疗FDG-PET阳性淋巴结转移的可切除胆道癌(KHBO1201):一项多中心II期临床试验

2025-11-010
OAAI
Response to the letter to the Editor: “Refining the Prognostic Utility of CA19-9 in Neoadjuvant Therapy for Pancreatic Cancer: Emphasizing Serial Monitoring and Subgroup Differentiation”

对致编辑信的回应:“优化CA19-9在胰腺癌新辅助治疗中的预后价值:强调系列监测和亚组区分”

2025-09-300
PRE
Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL-4, Enhancing Tumor Growth in Hepatocellular Carcinoma

肿瘤内皮细胞通过IL-4诱导M2型巨噬细胞极化,增强肝细胞癌的生长

2025-08-270
OAAI
Postoperative chemotherapy after conversion surgery for clinical stage IV gastric cancer: a propensity score-matched analysis

转化手术后临床IV期胃癌的术后化疗:一项倾向性评分匹配分析

2025-08-270
OA
Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy

胰腺癌新辅助治疗中放射学与病理学反应评估的差异:新辅助化疗与新辅助化放疗的比较

2025-06-280
OAAI
Adipose-derived stem cells using fibrin gel as a scaffold enhances post-hepatectomy liver regeneration (vol 15, 6334, 2025)

脂肪来源的干细胞使用纤维蛋白凝胶作为支架可增强肝切除术后肝脏再生(卷15,6334,2025)

2025-05-120
OA
Adipose-derived stem cells using fibrin gel as a scaffold enhances post-hepatectomy liver regeneration

以纤维蛋白凝胶为支架的脂肪干细胞促进肝切除术后肝再生

2025-02-210
OAAI